Evidence map›Paper›PMID 41558774›Full record

ArticleCanadian journal of surgery. Journal canadien de chirurgie

Health care costs of major upper-extremity amputations in Ontario: a retrospective matched-cohort analysis with considerations for transplantation.

Çağdaş Duru, Nina Hadzimustafic, Siba Haykal

Abstract read
In one paragraph

Article in Canadian journal of surgery. Journal canadien de chirurgie. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Çağdaş DuruFrom the Latner Thoracic Surgery Laboratories, University Health Network, Toronto, Ont. (Duru, Haykal); the Plastic and Reconstructive Surgery, McGill University, Montréal, Que. (Hadzimustafic); the Division of Plastic and Reconstructive Surgery, Department of Surgery, Yale University, New Haven, Conn. (Haykal).
Nina HadzimustaficFrom the Latner Thoracic Surgery Laboratories, University Health Network, Toronto, Ont. (Duru, Haykal); the Plastic and Reconstructive Surgery, McGill University, Montréal, Que. (Hadzimustafic); the Division of Plastic and Reconstructive Surgery, Department of Surgery, Yale University, New Haven, Conn. (Haykal).
Siba HaykalFrom the Latner Thoracic Surgery Laboratories, University Health Network, Toronto, Ont. (Duru, Haykal); the Plastic and Reconstructive Surgery, McGill University, Montréal, Que. (Hadzimustafic); the Division of Plastic and Reconstructive Surgery, Department of Surgery, Yale University, New Haven, Conn. (Haykal) siba.haykal@yale.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMajor upper-extremity amputation, defined as loss above the wrist, profoundly affects all aspects of life and imposes substantial health care burdens. Standard care involves prosthetics, which have limitations, while vascularized composite allotransplantation (VCA) offers improved functionality but raises cost-effectiveness concerns. We sought to evaluate health care use and cost of major upper-extremity amputation in Ontario.

methodsWe conducted a 20-year retrospective matched-cohort study using administrative health care data from Ontario. We matched patients with major upper-extremity amputations (April 2002 to March 2023) 4:1 with general population and hospital-based trauma controls. We analyzed health care use and costs by follow-up duration (1 yr, 1 to 4 yr, 5 to 9 yr, > 10 yr).

resultsWe identified 617 patients with a mean follow-up of 6.95 years, including 41.7% with traumatic amputations and 58.3% with nontraumatic amputations. Forearm-level amputations were most common. Median health care costs were $52 661 (interquartile range [IQR] $22 009 to $120 120) for traumatic amputations and $90 928 (IQR $43 128 to $213 034) for nontraumatic amputations, both exceeding controls. Bilateral amputations incurred higher costs than unilateral amputations ($104 895 [IQR $41 290 to $243 967] for traumatic and $117 006 [IQR $68 447 to $226 491] for nontraumatic cases), excluding prosthetics. Total treatment costs with myoelectric prosthetics exceeded $344 895 for patients with bilateral amputations and $171 860 for those unilateral amputations, surpassing prior projections.

conclusionAlthough lifetime VCA costs remain higher than for prosthetics, the lack of Canadian utility measures, societal cost data, and return-to-work outcomes underscores the need for further study to assess whether the functional and quality-of-life benefits could justify these expenditures for patients with bilateral amputations.

Indexed as

Amputation, SurgicalHealth Care CostsUpper ExtremityVascularized Composite AllotransplantationAdultAgedArtificial LimbsFemaleFollow-Up StudiesHumansMaleMiddle AgedOntarioRetrospective Studies

Identifiers

PMID41558774
PMCPMC12854802

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.